transplant infection disease - Yahoo News Search Results
First pediatric heart transplant recipient at CMH 'feels wonderful'
Children's Mercy Hospital performed its first pediatric heart transplant earlier this month and for the first time KCTV5 got a status report from the teenaged patient herself.
Reasons for ibrutinib therapy discontinuation in CLL
About 10 percent of patients with chronic lymphocytic leukemia discontinued therapy with the Bruton tyrosine kinase inhibitor drug ibrutinib because of disease progression during clinical trials, according to a new study.
Alexion Receives CHMP Positive Opinions for Important Updates to the EU Label for Soliris® (eculizumab)
Alexion announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a Positive Opinion to update the therapeutic indication for Soliris® in the treatment of paroxysmal nocturnal haemoglobinuria for patients with high disease activity regardless of history of transfusion.
Reasons for ibrutinib therapy discontinuation in patients with chronic lymphocytic leukemia
( The JAMA Network Journals ) About 10 percent of patients with chronic lymphocytic leukemia discontinued therapy with the Bruton tyrosine kinase inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online by JAMA Oncology.
NOSM Researchers Receive $100,000 for Immunization Study
A Northern Ontario School of Medicine (NOSM) faculty member is leading a team of researchers to find an optimal strategy to prevent severe pneumococcal infections in First Nations people suffering from chronic kidney disease–research that will be furthered by a $100,086 grant from Pfizer.
Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the ...
Leading advocacy and disease-awareness nonprofits applauds Centers for Disease Control & Prevention's new study that calls attention to nearly 500,000 Americans afflicted with Clostridium difficile infections annually, including 29,000 deaths linked to the disease. (PRWeb February 26, 2015) Read the full story at http://www.prweb.com/releases/2015/02/prweb12544201.htm
ADDING MULTIMEDIA REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients ...
BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. The REVLIMID Marketing Authorisation has been updated to ...
Chimerix Presents Update on Preliminary Data From AdVise Study of Brincidofovir for Adenovirus Infection at BMT Tandem ...
DURHAM, N.C. -- Chimerix, Inc. announced the presentation of preliminary data from the open-label, Phase 3 AdVise trial of brincidofovir for adenovirus infection showing a short-term mortality rate of ...
A Woman Became Obese After a Poop Transplant
Scientists have known for a while that gut bacteria can play a profound role in the weight of mice. Now we have a case report in humans that is not entirely surprising: A woman gained 36 pounds and became obese in the 16 months after a fecal transplant. Read more...
James Aaron Warrington, 27, from Macclesfield, died after a biopsy to help prepare him for an urgent double transplant.